AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| 1 |
Broadcom
AVGO
|
+$683M |
| 2 |
Cboe Global Markets
CBOE
|
+$403M |
| 3 |
Apple
AAPL
|
+$358M |
| 4 |
TSMC
TSM
|
+$352M |
| 5 |
Eli Lilly
LLY
|
+$328M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$1.29B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$636M |
| 3 |
West Pharmaceutical
WST
|
+$562M |
| 4 |
Idexx Laboratories
IDXX
|
+$444M |
| 5 |
Visa
V
|
+$387M |
Sector Composition
| 1 | Technology | 26.49% |
| 2 | Healthcare | 13.1% |
| 3 | Financials | 12.21% |
| 4 | Consumer Discretionary | 11.26% |
| 5 | Communication Services | 9.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Genco Shipping & Trading
GNK
$763M
| $572K | ﹤0.01% |
42,820
| – | – |
|
2502
Vitesse Energy
VTS
$992M
| $571K | ﹤0.01% |
23,203
+11
| +0% | +$270 |
|
2503
Gogo Inc
GOGO
$1.38B
| $568K | ﹤0.01% |
65,836
-200
| -0.3% | -$1.72K |
|
2504
AnaptysBio
ANAB
$649M
| $567K | ﹤0.01% |
30,520
| – | – |
|
2505
Rigel Pharmaceuticals
RIGL
$678M
| $566K | ﹤0.01% |
31,473
| – | – |
|
|
UHT
2506
Universal Health Realty Income Trust
UHT
$583M
| $565K | ﹤0.01% |
13,804
-685
| -5% | -$28.1K |
|
2507
V2X
VVX
$1.72B
| $565K | ﹤0.01% |
11,520
| – | – |
|
2508
Dream Finders Homes
DFH
$2.8B
| $561K | ﹤0.01% |
24,850
-1,161
| -4% | -$26.2K |
|
2509
Kura Oncology
KURA
$766M
| $560K | ﹤0.01% |
84,800
| – | – |
|
2510
Monro
MNRO
$534M
| $559K | ﹤0.01% |
38,660
| – | – |
|
2511
Columbia Financial
CLBK
$1.61B
| $558K | ﹤0.01% |
37,170
+10
| +0% | +$150 |
|
2512
Sezzle
SEZL
$2.98B
| $557K | ﹤0.01% |
15,960
-240
| -1% | -$8.37K |
|
2513
Cellebrite
CLBT
$4.2B
| $556K | ﹤0.01% |
28,633
| – | – |
|
|
ENFN
2514
DELISTED
Enfusion, Inc.
ENFN
| $553K | ﹤0.01% |
49,600
+8,860
| +22% | +$98.8K |
|
2515
GCM Grosvenor
GCMG
$684M
| $550K | ﹤0.01% |
41,570
+12,730
| +44% | +$168K |
|
|
GMRE
2516
Global Medical REIT
GMRE
$511M
| $545K | ﹤0.01% |
62,261
+2,861
| +5% | +$25K |
|
2517
The RealReal
REAL
$1.08B
| $544K | ﹤0.01% |
100,850
| – | – |
|
|
ADAM
2518
Adamas Trust, Inc. Common Stock
ADAM
$654M
| $543K | ﹤0.01% |
83,672
| – | – |
|
2519
PACS Group
PACS
$1.49B
| $539K | ﹤0.01% |
47,990
| – | – |
|
2520
CEVA Inc
CEVA
$570M
| $539K | ﹤0.01% |
21,047
| – | – |
|
2521
Vestis
VSTS
$575M
| $539K | ﹤0.01% |
54,425
-2,447
| -4% | -$24.2K |
|
2522
iRadimed
IRMD
$945M
| $539K | ﹤0.01% |
10,262
-370
| -3% | -$19.4K |
|
2523
Metals Acquisition
MTAL
$1.01B
| $538K | ﹤0.01% |
56,370
| – | – |
|
2524
Day One Biopharmaceuticals
DAWN
$755M
| $538K | ﹤0.01% |
67,790
-210
| -0.3% | -$1.67K |
|
2525
Eagle Bancorp Montana
EBMT
$140M
| $536K | ﹤0.01% |
31,984
-1,682
| -5% | -$28.2K |
|